Delivery Order SPE2DB20D3304-SPE2DB25FW7D7

Award Date 6/3/25
Potential Completion Date 6/4/25
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $7,738.81 and a period of performance through March 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,228.50 and a period of performance through February 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,638.00 and a period of performance through June 4, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,638.00 and a period of performance through May 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML, with a ceiling value of $1,991.10 and a performance period ending on April 24, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,340.71, is for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price delivery order with a final completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $8,435.89 and a period of performance through April 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $82,134.89 and a period of performance through February 21, 2025. The contract is a firm fixed price instrument, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug WEGOVY 0.5 mg/0.5 ml pen 0.5 ml, with a ceiling value of $16,478.51. The contract is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has a firm fixed price and a ceiling value of $41,111.47, with a performance period ending on April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW7D7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of the drug WEGOVY 0.5 mg/0.5 ml pen (0.5 ml) with a ceiling value of $9,096.71 and a period of performance through June 4, 2025. The contract is a firm fixed price delivery order and is not set aside for any specific business category.

AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX. This IDC serves as a comprehensive global pharmaceutical support vehicle, allowing the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/2/25, 9:43 AM